Abstract
Phaeochromocytomas arising in adrenal or extra-adrenal sites and paragangliomas of the head and neck, in particular of the carotid bodies, occur sporadically and also in a familial setting. In addition to mutations in RET and VHL in familial disease, germline mutations in SDHD and SDHB genes that encode subunits of mitochondrial complex II have also been associated with the development of familial phaeochromocytomas. To further investigate the role of SDHD and SDHB in the development of these tumours we determined the occurrence of germline SDHD and SDHB mutations in four patients with a family history of phaeochromocytoma with associated head and neck paraganglioma, one patient with a family history of phaeochromocytoma only and two patients with apparently sporadic extra-adrenal phaeochromocytoma, one of whom had early onset disease. Secondly, we investigated whether somatic SDHB mutations correlated with loss of heterozygosity at 1p36 in a subgroup of 11 sporadic and three MEN 2-associated RET-mutation-positive phaeochromocytomas. Novel SDHB mutations were identified in the probands from four families and two apparently sporadic cases (six of seven probands studied), including two missense mutations, a single nonsense and frameshift mutation, as well as two splice site mutations, one of which was shown to have partial penetrance resulting in ‘leaky’ splicing. Further, five intronic polymorphisms in SDHB were found. No SDHD mutations were identified. In addition, no somatic SDHB mutations were found in the remaining allele of the 11 sporadic adrenal phaeochromocytomas with allelic loss at 1p36 or the three MEN 2-associated RET-mutation-positive phaeochromocytomas. Therefore, we conclude that SDHB has a major role in the pathogenesis of familial phaeochromocytomas, but the possible role of SDHB in sporadic tumours showing allelic loss at 1p36 has yet to be ascertained.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Astuti D, Douglas F, Lennard TWJ, Aliganis IA, Woodward ER, Evans DGR, Eng C, Latif F and Maher ER . (2001a). Lancet., 357, 1181–1182.
Astuti D, Latif F, Dallol A, Dahia PLM, Douglas F, George E, Sköldberg F, Husebye ES, Eng C and Maher ER . (2001b). Am. J. Hum. Genet., 69, 49–54.
Astuti D, Latif F, Dallol A, Dahia PLM, Douglas F, George E, Sköldberg F, Husebye ES, Eng C and Maher ER . (2002). Am. J. Hum. Genet., 70, 565 (Erratum).
Baysal BE . (2001). Otolaryngol. Clin. North Am., 34, 863–879.
Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, van der May A, Taschner PEM, Rubinstein WS, Myers EN, Richard III CW, Cornelisse CJ, Devilee P and Devlin B . (2000). Science, 287, 848–851.
Baysal BE, Rubinstein WS and Taschner PEM . (2001). J. Mol. Med., 79, 495–503.
Baysal BE, Willett-Brozick JE, Lawrence EC, Drovdlic CM, Savul SA, McLeod DR, Yee HA, Brackmann DE, Slattery III WH, Myers EN, Ferrell RE and Rubenstein WS . (2002). J. Med. Genet., 39, 178–183.
Benn DE, Dwight T, Richardson AL, Delbridge L, Bambach CP, Stowasser M, Gordon RD, Marsh DJ and Robinson BG . (2000). Cancer Res., 60, 7048–7051.
Benn DE, Marsh DJ, and Robinson BG . (2002). Curr. Opin. Endocrinol., 9, 79–86.
Caron H, Spieker N, Godfried M, Veenstra M, van Sluis P, de Kraker J, Voûte P and Versteeg R . (2001). Genes Chromosome Cancer, 30, 168–174.
Edström Elder E, Nord B, Carling T, Juhlin C, Bäckdahl M, Höög A and Larsson K . (2002). World J. Surg., 26, 965–971.
Eng C, Crossey PA, Mulligan LM, Healey CS, Houghton C, Prowse A, Chew SL, Dahia PL, O'Riordan JL, Toledo SP, Smith DP, Maher ER and Ponder BAJ . (1995). J. Med. Genet., 32, 934–937.
Gimenez-Roqueplo A-P, Favier J, Rustin P, Rieubland C, Kerlan V, Plouin P-F, Rötig A and Jeunemaitre X . (2002). J. Clin. Endocrinol. Metab., 87, 4771–4774.
Gimm O, Armanios M, Dziema H, Neumann HPH and Eng C . (2000). Cancer Res., 60, 6822–6825.
Hofstra RM, Stelwagen T, Stulp RP, de Jong D, Hulsbeek M, Kamsteeg EJ, van den Berg A, Landsvater RM, Vermey A, Molenaar WM, Lips CJ and Buys, CH . (1996). J. Clin. Endocrinol. Metab., 81, 2881–2884.
Koch CA, Huang SC, Zhuang Z, Stolle C, Azumi N, Chrousos GP, Vortmeyer AO and Pacak K . (2002). Oncogene, 21, 479–482.
Knudson AG . (1993). Nat. Genet., 5, 103–104.
Lack EE . (1997). Atlas of Tumor Pathology: Tumours of the Adrenal Gland and Extra-Adrenal Paraganglia. Rosai J (ed). Armed Forces Institute of Pathology; Washington, pp. 223–259.
Lee SP, Nicholson GI and Hitchcock G . (1977). Pathology, 9, 173–177.
Leckschat S, Reamrobinson D and Scheffler IE . (1993). Somat. Cell Mol. Genet., 19, 505–511.
Neumann HPH, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoeffer C, Zerres K, Januszewicz A, Smith WM, Munk R, Manz T, Glaesker S, Apel TW, Treier M, Reineke M, Walz MK, Hoang-Vu C, Brauckhoff M, Klein-Franke A, Klose P, Schmidt H, Maier-Woelfle M, Peçzkowska M, Szmigielski C and Eng C . (2002). N. Engl. J. Med., 346, 1459–1466.
Niemann S and Müller U . (2000). Nat. Genet., 26, 268–270.
Scheffler IE . (1998). Prog. Nucleic Acid Res. Mol. Biol., 60, 267–315.
Solcia E, Klöppel G and Sobin LH et al (eds). (2000). World Health Organization International Histological Classification of Tumours: Histological Typing of Endocrine Tumours, 2nd edn. Springer: Berlin, London.
Svenson IK, Ashley-Koch AE, Pericak-Vance MA and Marchuk DA . (2001). Am. J. Hum. Genet., 69, 1407–1409.
Taschner PEM, Jansen JC, Baysal BE, Bosch A, Rosenberg EH, Bröcker-Vriends AHJT, van der May AGL, van Ommen G-JB, Cornelisse CJ and Devilee P . (2001). Genes Chromosomes Cancer, 31, 274–281.
Williamson C, Pannett AAJ, Pang JT, Wooding C, McCarthy M, Sheppard MN, Monson J, Clayton RN and Thakker RV . (1997). J. Med. Genet., 34, 617–661.
Acknowledgements
The following clinicians are thanked for their assistance with this project – Dr Bradley Fawkes, Professor Len Gray, Professor Ian Holdaway. Dr Warwick Inder, Dr Ken Maclean, Professor David Morris and Dr Marcus Vowells. Financial contributions in memory of two patients are gratefully acknowledged. DJM is the recipient of an RD Wright Fellowship, NHMRC, Australia.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Benn, D., Croxson, M., Tucker, K. et al. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas. Oncogene 22, 1358–1364 (2003). https://doi.org/10.1038/sj.onc.1206300
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206300
Keywords
This article is cited by
-
Carotid body tumor with neck metastasis due to germline SDHB variant: a case report and literature review
International Cancer Conference Journal (2022)
-
Mutational load in carotid body tumor
BMC Medical Genomics (2019)
-
Network-based analysis of oligodendrogliomas predicts novel cancer gene candidates within the region of the 1p/19q co-deletion
Acta Neuropathologica Communications (2018)
-
68Ga-DOTATATE PET–CT imaging in carotid body paragangliomas
Annals of Nuclear Medicine (2018)
-
Urinary Bladder Paragangliomas: Analysis of Succinate Dehydrogenase and Outcome
Endocrine Pathology (2016)